Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zahi Touma

Showing results (81-90 of 217) with videos related to

Pageof 22
Sort By:
The Journal of Rheumatology|July 1, 2025
Comparison of Lupus Nephritis Onset Before and After Age 50: Effect on Presentation and Outcomes in an Inception CohortFadi Kharouf, Pankti Mehta, Qixuan Li, et al.
Rheumatology (Oxford, England)|September 20, 2025
Is antimalarial use associated with a reduced risk of LN in patients with SLE? Results from an inception cohort-based studyFadi Kharouf, JuanPablo DiazMartinez, Pankti Mehta, et al.
Clinical and Experimental Rheumatology|July 14, 2026
Lupus nephritis outcomes when kidney biopsy is not feasible: findings from a tertiary centre inception cohortFadi Kharouf, Pankti Mehta, Qixuan Li, et al.
Arthritis Research & Therapy|October 27, 2015
Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosusJorge Medina-Rosas, Dafna D Gladman, Jiandong Su, et al.
Rheumatology (Oxford, England)|January 10, 2026
Comment on: Short and long-term outcomes of patients with pure membranous lupus nephritis compared to patients with proliferative disease: ReplyFadi Kharouf, Qixuan Li, Laura P Whittall Garcia, et al.
Rheumatology (Oxford, England)|September 2, 2025
Venous thromboembolism in patients with lupus nephritis: frequency and risk factors-a cohort studyFadi Kharouf, Pankti Mehta, Qixuan Li, et al.
Annals of the Rheumatic Diseases|August 4, 2021
Response to: Correspondence on "New EULAR/ACR 2019 SLE classification criteria: defining ominosity in SLE" by Pons-Estel <i>et al</i>Laura Whittall-Garcia, Dafna D Gladman, Murray Urowitz, et al.
Seminars in Arthritis and Rheumatism|April 20, 2025
Does the time to the onset of lupus nephritis impact renal disease presentation and outcomes?Fadi Kharouf, Pankti Mehta, Qixuan Li, et al.
Rheumatology (Oxford, England)|April 5, 2026
Antimalarial use and extra-renal damage accrual in lupus nephritis: a longitudinal cohort studyFadi Kharouf, Pankti Mehta, Qixuan Li, et al.
Seminars in Arthritis and Rheumatism|October 11, 2022
The new EULAR/ACR 2019 SLE classification criteria: A predictor of long-term outcomesLaura Whittall-Garcia, Dafna D Gladman, Murray B Urowitz, et al.
Pageof 22

Showing results (81-90 of 217) with videos related to

Sort By:
Pageof 22
The Journal of Rheumatology|July 1, 2025
Comparison of Lupus Nephritis Onset Before and After Age 50: Effect on Presentation and Outcomes in an Inception CohortFadi Kharouf, Pankti Mehta, Qixuan Li, et al.
Rheumatology (Oxford, England)|September 20, 2025
Is antimalarial use associated with a reduced risk of LN in patients with SLE? Results from an inception cohort-based studyFadi Kharouf, JuanPablo DiazMartinez, Pankti Mehta, et al.
Clinical and Experimental Rheumatology|July 14, 2026
Lupus nephritis outcomes when kidney biopsy is not feasible: findings from a tertiary centre inception cohortFadi Kharouf, Pankti Mehta, Qixuan Li, et al.
Arthritis Research & Therapy|October 27, 2015
Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosusJorge Medina-Rosas, Dafna D Gladman, Jiandong Su, et al.
Rheumatology (Oxford, England)|January 10, 2026
Comment on: Short and long-term outcomes of patients with pure membranous lupus nephritis compared to patients with proliferative disease: ReplyFadi Kharouf, Qixuan Li, Laura P Whittall Garcia, et al.
Rheumatology (Oxford, England)|September 2, 2025
Venous thromboembolism in patients with lupus nephritis: frequency and risk factors-a cohort studyFadi Kharouf, Pankti Mehta, Qixuan Li, et al.
Annals of the Rheumatic Diseases|August 4, 2021
Response to: Correspondence on "New EULAR/ACR 2019 SLE classification criteria: defining ominosity in SLE" by Pons-Estel <i>et al</i>Laura Whittall-Garcia, Dafna D Gladman, Murray Urowitz, et al.
Seminars in Arthritis and Rheumatism|April 20, 2025
Does the time to the onset of lupus nephritis impact renal disease presentation and outcomes?Fadi Kharouf, Pankti Mehta, Qixuan Li, et al.
Rheumatology (Oxford, England)|April 5, 2026
Antimalarial use and extra-renal damage accrual in lupus nephritis: a longitudinal cohort studyFadi Kharouf, Pankti Mehta, Qixuan Li, et al.
Seminars in Arthritis and Rheumatism|October 11, 2022
The new EULAR/ACR 2019 SLE classification criteria: A predictor of long-term outcomesLaura Whittall-Garcia, Dafna D Gladman, Murray B Urowitz, et al.
Pageof 22